| Literature DB >> 29843405 |
Zhi-Yong Guo1,2, Ming-Hui Tan3, Cheng-Xiong Liu4, Meng-Meng Lv5, Zhang-Shuang Deng6,7, Fei Cao8, Kun Zou9, Peter Proksch10.
Abstract
Aspergoterpenins A⁻D (1⁻4), four new bisabolane sesquiterpenoid derivatives, were obtained from the endophytic fungus, Aspergillus versicolor, together with eight known compounds (5⁻12), and their structures were elucidated by a comprehensive analysis of their NMR (Nuclear Magnetic Resonance), MS (Mass Spectrum) and CD (Circular Dichroism) spectra. Aspergoterpenin A (1) was the first example with a characteristic ketal bridged-ring part in the degraded natural bisabolane-type sesquiterpene structures. The compounds 1⁻12 displayed no significant activities against four cancer cell lines (A549, Caski, HepG2 and MCF-7). Further, the antimicrobial activities to Erwinia carotovora sub sp. Carotovora were evaluated, and the results showed that compounds 1⁻12 displayed antimicrobial activities with MIC values ranging from 15.2 to 85.2 μg/mL.Entities:
Keywords: Aspergillus versicolor; antimicrobial activities; bisabolanese squiterpenoid; endophytic fungus; structural elucidation
Mesh:
Substances:
Year: 2018 PMID: 29843405 PMCID: PMC6100428 DOI: 10.3390/molecules23061291
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
The 13C-NMR data of compounds 1–4 (100 MHz, CD3OD-d).
| No. | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| 1 | 154.8 (C) | 156.8 (C) | 157.0 (C) | 156.8 (C) |
| 2 | 132.8 (C) | 137.2 (C) | 138.3 (C) | 137.6 (C) |
| 3 | 125.2 (CH) | 127.6 (CH) | 127.9 (CH) | 127.7 (CH) |
| 4 | 121.9 (CH) | 121.5 (CH) | 121.3 (CH) | 121.5 (CH) |
| 5 | 131.9 (C) | 133.5 (C) | 131.0 (C) | 132.5 (C) |
| 6 | 117.0 (CH) | 118.6 (CH) | 118.3 (CH) | 118.6 (CH) |
| 7 | 169.7 (C) | 171.3 (C) | 168.5 (C) | 169.9 (C) |
| 8 | 74.9 (C) | 77.8 (C) | 77.8 (C) | 77.7 (C) |
| 9 | 38.1 (CH2) | 43.3 (CH2) | 43.9 (CH2) | 43.4 (CH2) |
| 10 | 18.3 (CH2) | 23.0 (CH2) | 19.9 (CH2) | 22.4 (CH2) |
| 11 | 36.5 (CH2) | 35.4 (CH2) | 45.0 (CH2) | 34.7 (CH2) |
| 12 | 100.9 (C) | 40.9 (CH) | 71.4 (C) | 33.7 (CH) |
| 13 | 28.6 (CH3) | 181.6 (C) | 29.2 (CH3) | 17.1 (CH3) |
| 14 | 26.9 (CH3) | 17.7 (CH3) | 29.1 (CH3) | 70.5 (CH2) |
| 15 | - | 28.9 (CH3) | 28.8 (CH3) | 28.8 (CH3) |
| 16 | - | - | 52.5 (CH3)(COO | 173.1 (C)(CO |
| CO | - | - | - | 20.8 (CH3) |
Figure 1Thestructures of compounds 1–12.
Figure 2The COSY and key HMBC NMR correlations of compounds 1–4.
Figure 3The calculated ECD and experimental CD spectra of compound 1.
The 1H-NMR data of compounds 1–4 (400 MHz, CD3OD-d).
| No. | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| 3 | 7.16 (d, 8.0, 1H) | 7.24 (d, 8.2, 1H) | 7.30 (d, 8.2, 1H) | 7.27 (d, 8.0, 1H) |
| 4 | 7.50 (dd, 1.7, 8.0, 1H) | 7.43 (d, 8.4, 1H) | 7.44 (dd, 1.8, 8.2,1H) | 7.44 (d, 8.0, 1H) |
| 5 | - | - | - | - |
| 6 | 7.34 (d, 1.7, 1H) | 7.36 (br s, 1H) | 7.36 (d, 1.8, 1H) | 7.38 (br s, 1H) |
| 7 | - | - | - | - |
| 8 | - | - | - | - |
| 9 | 1.81 (td, 4.2, 13.3, 1H)1.70 (m, 1H) | 1.99 (m, 1H)1.81 (m, 1H) | 1.98 (m, 1H)1.80 (m, 1H) | 1.96(m, 1H)1.81(m, 1H) |
| 10 | 1.62 (m, 1H)1.45 (m, 1H) | 1.35 (m, 1H)1.21 (m, 1H) | 1.39 (m, 1H)1.25(m, 1H) | 1.29 (m,2H) |
| 11 | 1.97 (br d, 13.3, 1H)1.73 (m, 1H) | 1.58 (m, 1H)1.34 (m, 1H) | 1.39 (m, 2H) | 1.35 (m, 1H)1.11 (m, 1H) |
| 12 | - | 2.34 (m, 1H) | - | 1.72 (m, 1H) |
| 13 | 1.50 (s, 3H) | - | 1.01 (s, 3H) | 0.86 (d, 6.8, 3H) |
| 14 | 1.60 (s, 3H) | 1.07 (d, 7.0, 3H) | 1.01 (s, 3H) | 3.88 (m, 1H)3.80 (m, 1H) |
| 15 | - | 1.59 (s, 3H) | 1.60 (s, 3H) | 1.60 (s, 3H) |
| COO | - | - | 3.88 (s, 3H) | - |
| CO | - | - | - | 2.00 (s, 3H) |
Figure 4The CD spectra of compounds 2–5. (A for compound 2, B for compound 3, C for compound 4 and D for compound 5).
The biological activity assays data of 1–12.
| No. | Anticanceractivity (IC50 in μg/mL) | Antimicobial Activity(MIC in μg/mL) | |||
|---|---|---|---|---|---|
| A549 | Caski | HepG2 | MCF-7 |
| |
| 1 | 54.2 | 58.3 | 80.3 | 90.6 | 15.2 |
| 2 | 65.4 | 75.3 | 90.8 | 57.4 | 35.6 |
| 3 | 67.3 | 73.5 | 69.5 | 64.4 | 40.5 |
| 4 | 85.6 | 85.5 | 74.4 | 88.7 | 50.8 |
| 5 | 72.2 | 92.2 | 75.7 | 65.3 | 64.3 |
| 6 | 90.6 | 78.2 | 75.8 | 80.4 | 68.9 |
| 7 | 82.5 | 90.4 | 60.5 | 77.5 | 75.2 |
| 8 | 64.4 | 65.6 | 59.2 | 64.1 | 85.2 |
| 9 | 89.7 | 83.5 | 76.2 | 79.1 | 68.8 |
| 10 | 94.2 | 90.4 | 88.2 | 96.8 | 75.3 |
| 11 | 100.1 | 95.3 | 100.5 | 78.9 | 65.4 |
| 12 | 55.6 | 85.2 | 78.8 | 65.4 | 50.9 |